NCT00108368View on ClinicalTrials.gov

The Effects of Risperidone and Olanzapine on Thinking

PHASE4CompletedINTERVENTIONAL
Timeline

Start Date

October 31, 2003

Study Completion Date

March 31, 2006

Conditions
SchizophreniaPsychotic Disorders
Interventions
DRUG

Risperidone

DRUG

Olanzapine

Trial Locations (1)

90073

VA Greater Los Angeles Healthcare System, Los Angeles

All Listed Sponsors
collaborator

Janssen, LP

INDUSTRY

lead

US Department of Veterans Affairs

FED

NCT00108368 - The Effects of Risperidone and Olanzapine on Thinking | Biotech Hunter | Biotech Hunter